News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
573,474 Results
Type
Article (36710)
Company Profile (217)
Press Release (536547)
Section
Business (159838)
Career Advice (854)
Deals (27439)
Drug Delivery (89)
Drug Development (63600)
Employer Resources (103)
FDA (14651)
Job Trends (12767)
News (271564)
Policy (27087)
Tag
Academia (2548)
Alliances (44741)
Alzheimer's disease (1077)
Approvals (14621)
Artificial intelligence (149)
Bankruptcy (207)
Best Places to Work (10860)
Biotechnology (142)
Breast cancer (110)
Cancer (937)
Cardiovascular disease (93)
Career advice (764)
Cell therapy (203)
Clinical research (50457)
Collaboration (390)
Compensation (100)
COVID-19 (2467)
C-suite (89)
Data (1052)
Diabetes (137)
Diagnostics (6083)
Earnings (56228)
Employer resources (90)
Events (97716)
Executive appointments (270)
FDA (15174)
Funding (337)
Gene therapy (146)
GLP-1 (518)
Government (4412)
Healthcare (17872)
Infectious disease (2551)
Inflammatory bowel disease (97)
Interviews (101)
IPO (12171)
Job creations (2318)
Job search strategy (683)
Layoffs (261)
Legal (5490)
Lung cancer (135)
Manufacturing (157)
Medical device (12989)
Medtech (12994)
Mergers & acquisitions (15403)
Metabolic disorders (385)
Neuroscience (1312)
NextGen Class of 2024 (6186)
Non-profit (4269)
Northern California (1303)
Obesity (223)
Opinion (149)
Patents (98)
People (46876)
Phase I (16209)
Phase II (21949)
Phase III (16408)
Pipeline (403)
Postmarket research (1910)
Preclinical (6585)
Radiopharmaceuticals (216)
Rare diseases (201)
Real estate (4648)
Regulatory (18324)
Research institute (2262)
Resumes & cover letters (102)
Southern California (1138)
Startups (3220)
United States (12118)
Vaccines (533)
Weight loss (167)
Date
Today (23)
Last 7 days (452)
Last 30 days (3198)
Last 365 days (31538)
2024 (29303)
2023 (35305)
2022 (46148)
2021 (50206)
2020 (49403)
2019 (43597)
2018 (32712)
2017 (27708)
2016 (27698)
2015 (32551)
2014 (24766)
2013 (20379)
2012 (21749)
2011 (22262)
2010 (20275)
Location
Africa (646)
Arizona (145)
Asia (34015)
Australia (5735)
California (2902)
Canada (1153)
China (237)
Colorado (142)
Connecticut (150)
Europe (74243)
Florida (413)
Georgia (115)
Illinois (308)
Indiana (188)
Kansas (96)
Maryland (557)
Massachusetts (2246)
Michigan (170)
Minnesota (234)
New Jersey (889)
New York (821)
North Carolina (663)
Northern California (1303)
Ohio (123)
Pennsylvania (755)
South America (918)
Southern California (1138)
Texas (410)
Utah (96)
Washington State (344)
573,474 Results for "sprig oral health technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Jaguar Health Launches FDA-Approved Oral Mucositis Prescription Product Gelclair in the U.S.
October 17, 2024
·
10 min read
Biotech Bay
Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product
Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”) today announced that it is initiating the company’s commercial footprint in its core focus area of cancer supportive care at the May 31 - June 4 American Society of Clinical Oncology (ASCO) Annual Meeting with a Napo Pharmaceuticals (Napo) exhibit booth for Gelclair®, the FDA-approved oral mucositis prescription product Jaguar in-licensed last month for the U.S. market.
May 23, 2024
·
9 min read
Approvals
Iterum Wins FDA Approval For Oral UTI Antibiotic, Seeks ‘Strategic Transaction’ for Asset
Orlynvah is the first oral penem approved in the U.S. and Iterum Therapeutics’ first FDA-approved product. CEO Corey Fishman said the company will renew its efforts to look for a potential partner to maximize value for its stakeholders.
October 28, 2024
·
2 min read
·
Tristan Manalac
Rapafusyn Pharmaceuticals is pleased to announce two upcoming presentations at Cambridge Health Institute’s 12th Annual Oral Peptides & Macrocyclics Conference, April 1 – 4 in San Diego.
Rapafusyn Pharmaceuticals is pleased to announce two upcoming presentations at Cambridge Health Institute’s 12th Annual Oral Peptides & Macrocyclics Conference, April 1 – 4 in San Diego.
April 1, 2024
·
2 min read
Press Releases
Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
September 26, 2024
·
7 min read
Press Releases
WellSync and Marius Pharmaceuticals Collaborate to Offer FDA-approved Oral Testosterone Replacement Therapy, Expanding Virtual Care for Men’s Health
September 9, 2024
·
3 min read
Press Releases
Tonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS)
August 21, 2024
·
6 min read
Pharm Country
ECRI names Clinica Imbanaco winner of the 2024 Health Technology Excellence Award
ECRI, a global independent healthcare and patient safety nonprofit, names Clinica Imbanaco the winner of its 2024 Health Technology Excellence Award.
June 28, 2024
·
4 min read
Press Releases
Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs
November 25, 2024
·
6 min read
Boehringer Ingelheim receives Health Canada approval for SENVELGO™, the once-daily liquid oral solution for newly diagnosed diabetes in cats
Boehringer Ingelheim announced that SENVELGO™, a revolutionary new treatment for cats with diabetes, has been approved by Health Canada, marking a significant step in the treatment of feline diabetes in Canada.
May 7, 2024
·
3 min read
1 of 57,348
Next
